Tag: CanSino

Vials of a COVID-19 vaccine patient, a recombinant adenovirus vaccine named Ad5-nCoV, developed by Chinese biopharmaceutical firm CanSino Biologics Inc. China has granted the first invention patent to a vaccine…

On July 6th, CEO of AJM Pharma, Adnan Hussain, signed an MoU with CanSino Biologics INC (CanSinoBIO), a China-based vaccine developer, to collaborate on a Covid-19 vaccine. By Reuters CanSino…